VSL#3®probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis

Synbiotics and probiotics in the critically ill after the PROPATRIA trial

(2012) Lee E. Morrow et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome

(2011) C. N. Andrews et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis

(2011) S. Moller et al.   GUT

Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial

(2009) Juan G. Abraldes et al.   GASTROENTEROLOGY

Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial

(2009) William Kemp et al.   LIVER INTERNATIONAL

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study

(2009) Puneeta Tandon et al.   LIVER INTERNATIONAL

The clinical use of HVPG measurements in chronic liver disease

(2009) Jaime Bosch et al.   Nature Reviews Gastroenterology & Hepatology

Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy

(2008) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy

(2008) Praveen Sharma et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

(2008) Vanessa Stadlbauer et al.   JOURNAL OF HEPATOLOGY